IE
ZURA icon

Israel Englander’s Zura Bio ZURA Stock Holding History

Israel Englander’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-65,000
Closed -$30K – 7586
2021
Q4 		$30K Buy
+65,000
New +$642K ﹤0.01% 6570

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Israel Englander's ZURA Position: Q2 2026 in Review

Israel Englander reduced its Zura Bio (ZURA) stake by 91% in Q2 2026, selling an estimated $6.53M and leaving 137,639 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #4459.

Israel Englander first reported a position in ZURA in Q4 2021 and has held it in 13 quarters since. The position peaked at $8.97M in Q1 2026. 94 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Israel Englander held 137,639 shares of Zura Bio worth $812K as of Q2 2026.
  • Israel Englander sold 1,370,424 Zura Bio shares in Q2 2026, an estimated $6.53M.
  • Zura Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4459 holding.
  • Israel Englander first reported a position in Zura Bio in Q4 2021 and has held it in 13 quarters since.
  • Israel Englander's Zura Bio position peaked at $8.97M in Q1 2026.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.